½Å°æÀÚ±Ø ±â±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : ¿ëµµº°, ±â±âº°, Áö¿ªº° - ½ÃÀå ¿¹Ãø(2025-2034³â)
Neurostimulation Devices Market Size, Share, Trends, Industry Analysis Report: By Application, Devices, and Region - Market Forecast, 2025-2034
»óǰÄÚµå : 1762257
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 116 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 5,889,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,275,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,661,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è ½Å°æÀÚ±Ø ±â±â ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 236¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

½Å°æÀÚ±Ø ±â±â ½ÃÀåÀº ½Å°æ Ȱµ¿À» Á¶ÀýÇϱâ À§ÇØ ½Å°æ°è¿¡ Àü±âÀû ÀÚ±ØÀ» °ø±ÞÇÏ´Â ÀÇ·á±â±â·Î ±¸¼ºµÇ¸ç, ÁÖ·Î ¸¸¼º ÅëÁõ, °£Áú, ÆÄŲ½¼º´, º»Å¼º ÁøÀü, ±âŸ ½Å°æ ÁúȯÀÇ °ü¸®¿¡ »ç¿ëµË´Ï´Ù.

½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡, ÃÖ¼Òħ½ÀÀû Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, AI ÅëÇÕ ¹× ¹«¼± Àڱذú °°Àº ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ ½Å°æÀÚ±Ø ±â±â ½ÃÀåÀº Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ½Å°æÀÚ±Ø ±â±âÀÇ ½ÃÀå ±âȸ´Â ½ÅÈï ½ÃÀå¿¡¼­ ÀÌ·¯ÇÑ ÀåÄ¡ÀÇ Ã¤Åà Ȯ´ë¿Í ÇÔ²² ÀÎÁö Àå¾Ö ¹× ºñ¸¸ °ü¸®¿Í °°Àº ±âÁ¸ ÀûÀÀÁõ ¿ÜÀÇ ´Ù¸¥ ¿ëµµ·ÎÀÇ È®Àå¿¡ ÀÖ½À´Ï´Ù.

ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÃæÀü½Ä ¹× ¼ÒÇüÈ­ ÀåÄ¡ °³¹ß, ¾÷°è Ç÷¹ÀÌ¾î °£ÀÇ Àü·«Àû Á¦ÈÞ, ½Å°æÀÚ±Ø ±â±â ½ÃÀå È®´ë¸¦ ÃËÁøÇÏ´Â ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ µîÀÌ ÀÖ½À´Ï´Ù. ÇコÄɾî ÀÎÇÁ¶ó°¡ ±¸ÃàµÇ°í ÀÎÁöµµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀåÀº ±â¼ú Çõ½Å°ú ÁøÈ­Çϴ ȯÀÚµéÀÇ ¿ä±¸¿¡ ÈûÀÔ¾î ²ÙÁØÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

½Å°æÀÚ±Ø ±â±â ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¿ëµµº°·Î´Â ¸¸¼º ÅëÁõ ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ô¼ö Àڱرâ äÅà Áõ°¡·Î ÀÎÇØ ÅëÁõ °ü¸® ºÐ¾ß°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

±â±âº°·Î´Â ÆÄŲ½¼º´, º»Å¼º ÁøÀü µî ¿îµ¿Àå¾Ö¿¡ ´ëÇÑ »ç¿ë È®´ë¿¡ ÈûÀÔ¾î ³ú½ÉºÎÀڱرⰡ °¡Àå ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì´Â ³ôÀº ÀÇ·áºñ ÁöÃâ, °­·ÂÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ½Å°æÀÚ±Ø ±â±âÀÇ º¸±ÞÀ¸·Î ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á ÀÎÇÁ¶ó °³¼±, ÀÎÁöµµ Çâ»ó, ½Å°æÁúȯ À¯º´·ü Áõ°¡ µîÀ» ¹è°æÀ¸·Î Å« ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

½Å°æÀÚ±Ø ±â±â ½ÃÀå¿¡´Â ÀÇ·á ±â¼ú ¹ßÀü¿¡ Àû±ØÀûÀ¸·Î ±â¿©Çϰí ÀÖ´Â ¿©·¯ ÁÖ¿ä ±â¾÷µéÀÌ ÀÖ½À´Ï´Ù. ÁÖ¿ä ±â¾÷À¸·Î´Â Abbott Laboratories, Aleva Neurotherapeutics, Boston Scientific Corporation, Cognito Therapeutics, ElectroCore, Inc, LivaNova PLC, Medtronic plc, Nalu Medical, Inc, Neuronetics, Inc, NeuroPace, Inc, Nevro Corp. Medtronic plc, Nalu Medical, Inc, Neuronetics, Inc, NeuroPace, Inc, Nevro Corp, Synapse Biomedical Inc µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ½Å°æÀÚ±Ø ±â±â ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ ½Å°æÀÚ±Ø ±â±â ½ÃÀå : ¿ëµµº°

Á¦6Àå ¼¼°èÀÇ ½Å°æÀÚ±Ø ±â±â ½ÃÀå : ±â±âº°

Á¦7Àå ¼¼°èÀÇ ½Å°æÀÚ±Ø ±â±â ½ÃÀå : Áö¿ª

Á¦8Àå °æÀï ±¸µµ

Á¦9Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global neurostimulation devices market size is expected to reach USD 23.63 billion by 2034, according to a new study by Polaris Market Research. The report "Neurostimulation Devices Market Size, Share, Trends, Industry Analysis Report: By Application (Pain Management, Epilepsy, Essential Tremor, Urinary & Faecal Incontinence, and Depression), Devices, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The neurostimulation devices market consists of medical devices that deliver electrical impulses to the nervous system to modulate neural activity, primarily used for managing chronic pain, epilepsy, Parkinson's disease, essential tremor, and other neurological conditions.

The market is experiencing significant growth due to the rising prevalence of neurological disorders, increasing demand for minimally invasive treatment options, and advancements in technology, including AI integration and wireless stimulation. Neurostimulation devices market opportunities lie in expanding applications beyond traditional indications, such as in cognitive disorders and obesity management, along with the growing adoption of these devices in emerging markets.

Key trends include the development of rechargeable and miniaturized devices, strategic collaborations among industry players, and regulatory approvals facilitating neurostimulation devices market expansion. As healthcare infrastructure improves and awareness increases, the market continues to witness steady growth, driven by innovation and evolving patient needs.

Neurostimulation Devices Market Report Highlights

By application, the pain management segment holds the largest market share due to the rising prevalence of chronic pain conditions and the increasing adoption of spinal cord stimulators.

By devices, the deep brain stimulators segment is experiencing the fastest growth, supported by their expanding use in movement disorders such as Parkinson's disease and essential tremor.

North America leads the market due to high healthcare spending, strong regulatory approvals, and widespread adoption of neurostimulation devices.

Asia Pacific is experiencing significant growth, driven by improving healthcare infrastructure, rising awareness, and increasing prevalence of neurological disorders.

The neurostimulation devices market features several key players actively contributing to advancements in medical technology. Prominent companies include Abbott Laboratories; Aleva Neurotherapeutics; Boston Scientific Corporation; Cognito Therapeutics; ElectroCore, Inc.; LivaNova PLC; Medtronic plc; Nalu Medical, Inc.; Neuronetics, Inc.; NeuroPace, Inc.; Nevro Corp.; and Synapse Biomedical Inc.

Polaris Market Research has segmented the neurostimulation devices market report on the basis of application, devices, and region:

By Application Outlook (Revenue - USD Billion, 2020-2034)

Pain Management

Epilepsy

Essential Tremor

Urinary & Faecal Incontinence

Depression

By Devices Outlook (Revenue - USD Billion, 2020-2034)

Spinal Cord Stimulator

Deep Brain Stimulator

Sacral Nerve Stimulator

Vagus Nerve Stimulator

Gastric Electric Stimulator

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Neurostimulation Devices Market Insights

5. Global Neurostimulation Devices Market, by Application

6. Global Neurostimulation Devices Market, by Devices

7. Global Neurostimulation Devices Market, by Geography

8. Competitive Landscape

9. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â